Zróżnicowanie szczepów Escherichia coli wytwarzających beta-laktamazy o rozszerzonym spektrum substratowym

ARTYKUŁ PRZEGLĄDOWY

Zróżnicowanie szczepów Escherichia coli wytwarzających beta-laktamazy o rozszerzonym spektrum substratowym

Patrycja Zalas-Więcek 1 , Tomasz Bogiel 1 , Krzysztof Wiśniewski 1 , Eugenia Gospodarek-Komkowska 1

1. Department of Microbiology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń

Opublikowany: 2017-03-27
DOI: 10.5604/01.3001.0010.3806
GICID: 01.3001.0010.3806
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2017; 71 : 214-219

 

Abstrakt

Przypisy

  • 1. Brolund A., Hæggman S., Edquist P.J., Gezelius L., Olsson-Liljequist B., Wisell K.T., Giske C.G.: The DiversiLab system versus pulsedfield gel electrophoresis: characterization of extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. J. Microbiol. Methods, 2010; 83: 224-230
    Google Scholar
  • 2. Burke L., Humphreys H., Fitzgerald-Hughes D.: The revolving door between hospital and community: extended-spectrum betalactamase-producing Escherichia coli in Dublin. J. Hosp. Infect., 2012; 81: 192-198
    Google Scholar
  • 3. Carattoli A., García-Fernández A., Varesi P., Fortini D., Gerardi S., Penni A., Mancini C., Giordano A.: Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J. Clin. Microbiol., 2008; 46: 103-108
    Google Scholar
  • 4. Da Silva G.J., Mendonça N.: Association between antimicrobial resistance and virulence in Escherichia coli. Virulence, 2012; 3: 18-28
    Google Scholar
  • 5. EARS‐Net Report for Quarter 3 2013. http://www.hpsc.ie/A-Z/ MicrobiologyAntimicrobialResistance/EuropeanAntimicrobialResistanceSurveillanceSystemEARSS/EARSSSurveillanceReports/20 13Reports/File,14430,en.pdf (03.12.2014)
    Google Scholar
  • 6. Ejrnaes K., Sandvang D., Lundgren B., Ferry S., Holm S., Monsen T., Lundholm R., Frimodt-Moller N.: Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. J. Clin. Microbiol., 2006; 44: 1776-1781
    Google Scholar
  • 7. European committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters (2013, version 3.1). http://www.eucast.org/fileadmin/src/media/ PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_3.1.pdf (10.11.2014)
    Google Scholar
  • 8. Peirano G., Costello M., Pitout J.D.: Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents, 2010; 36: 19-23
    Google Scholar
  • 9. Sabat A.J., Budimir A., Nashev D., Sá-Leão R., van Dijl J.M., Laurent F., Grundmann H., Friedrich A.W.: Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro Surveill. 2013; 18: 20380. http://www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=20380 (03.03.2015)
    Google Scholar
  • 10. Schwaber M.J., Navon-Venezia S., Kaye K.S., Ben-Ami R., Schwartz D., Carmeli Y.: Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother., 2006; 50: 1257-1262
    Google Scholar
  • 11. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., Citton R., D’Inzeo T., Fadda G., Cauda R., Spanu T.: Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother., 2007; 51: 1987-1994
    Google Scholar

Pełna treść artykułu

Przejdź do treści